Gut Microbiome Modulation as a Novel Therapeutic Strategy for Type-2 Diabetes Mellitus
Received Date: Jan 01, 2024 / Published Date: Jan 29, 2024
Abstract
Type-2 Diabetes Mellitus (T2DM) poses a significant global health burden, affecting millions worldwide. Despite extensive research, current treatment options often fall short in managing this complex metabolic disorder. Recently, there has been growing interest in the role of the gut microbiome in T2DM pathogenesis, presenting a promising avenue for novel therapeutic interventions. This article explores the intricate relationship between the gut microbiome and T2DM, highlighting emerging research on microbiome modulation as a potential therapeutic strategy.
Citation: Tomasz C (2024) Gut Microbiome Modulation as a Novel TherapeuticStrategy for Type-2 Diabetes Mellitus. J Diabetes Clin Prac 7: 225. Doi: 10.4172/jdce.1000225
Copyright: © 2024 Tomasz C. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Recommended Journals
天美传媒 Access Journals
Article Tools
Article Usage
- Total views: 262
- [From(publication date): 0-2024 - Jan 11, 2025]
- Breakdown by view type
- HTML page views: 227
- PDF downloads: 35
